XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Capital Stock (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
shares
Mar. 31, 2022
USD ($)
Dec. 31, 2022
shares
Dec. 31, 2021
$ / shares
shares
Aug. 11, 2021
Jun. 30, 2018
shares
Stock-based compensation disclosure            
Proceeds from issuance of common stock under stock plans | $ $ 39 $ 620        
ESPP            
Stock-based compensation disclosure            
Aggregate number of common shares reserved for future issuance           2,000,000
Pre-Funded Warrants            
Stock-based compensation disclosure            
Warrant exercise price | $ / shares       $ 0.01    
Threshold percentage of common stock owned that limits the number of warrants exercised         9.99  
Maximum percentage upon at least 61 days prior notice from the investor to the Company         19.99  
Stock options            
Stock-based compensation disclosure            
Stock options granted to directors (in shares) 4,757,000          
Options exercised (in shares) 16,000          
Securities Purchase Agreement | RA Capital Healthcare Fund, L.P. | Pre-Funded Warrants            
Stock-based compensation disclosure            
Pre-Funded warrants issued to purchase shares       21,434,782    
Securities Purchase Agreement | Redmile Group LLC | Pre-Funded Warrants            
Stock-based compensation disclosure            
Pre-Funded warrants issued to purchase shares       11,363,636    
Compensation Policy for Non-Employee Directors | Stock options            
Stock-based compensation disclosure            
Stock options granted to directors (in shares)     321,622 352,000